# Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
Canonical URL: https://biopharmsignal.com/news/INSM/insmed-reports-first-quarter-2026-financial-results-and-provides-business-update
Ticker: INSM
Company: Insmed
Source: Insmed
Published: 2026-05-07 11:00 EST
Original Source URL: https://investor.insmed.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-16 11:00 EST — [Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension](https://biopharmsignal.com/news/INSM/insmed-announces-positive-12-month-data-from-the-ongoing-open-label-extension-st-7880862e) — Source: Insmed
- 2026-06-23 11:00 EST — [Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory](https://biopharmsignal.com/news/INSM/insmed-appoints-samuele-butera-as-senior-vice-president-general-manager-global-r-5bfb9a1f) — Source: Insmed
- 2026-06-04 11:00 EST — [Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/INSM/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Insmed
- 2026-05-27 11:00 EST — [Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference](https://biopharmsignal.com/news/INSM/insmed-to-present-at-the-2026-goldman-sachs-annual-global-healthcare-conference) — Source: Insmed
- 2026-05-07 11:00 EST — [Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/INSM/insmed-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: Insmed
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)